Table 2 Anamnestic and laboratory measurement data of type 2 diabetes patients

Age [years]

63.0 ± 11.6

58.4 ± 14.6

0.0589

Duration of diabetes [years]

13.7 ± 10.3

–

–

Chromogranin A [ng/mL] ^a

57.80 ± 34.74

49.97 ± 22.29

0.1587

Chromogranin B [ng/mL]

99.72 ± 54.79

112.54 ± 61.68

0.1698

HbA_1C [%]

7.3 ± 1.2

–

–

HbA_1C [mmol/mol]

56.0 ± 13.1

–

–

White blood cell count [10⁹/L]

7.93 ± 2.08

7.21 ± 1.91

0.0443

Red blood cell count [10¹²/L]

4.82 ± 0.39

5.01 ± 0.56

0.0389

eGFR [mLmin⁻¹(1.73m²)⁻¹]

83.49 ± 17.84

90.19 ± 13.13

0.0117

Body mass index (BMI) [kg/m²]

31.1 ± 5.8

27.9 ± 5.4

0.0017

Sex (Female / Male)

50: 50

24: 23

1.0000

Hypertension

91

17

 < 0.0001

Thyroid disease

16

4

0.3038

Gastroesophageal reflux disease

31

5

0.0074

Antacid therapy

29

3

0.0013